BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Breast Cancer
,
Lung
,
DNA fingerprint
,
Doxorubicin
,
FXYD4
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
miR 194
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Prostate cancer 22RV1 cells with miR-194 mimic overexpression
Explore Curated Studies Results
Literature
Most Relevant Literature
miR-194-5p serves a suppressive role in human keloid fibroblasts via targeting NR2F2.
Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients.
miR-194 relieve neuropathic pain and prevent neuroinflammation via targeting FOXA1.
miR-194-Loaded Gelatin Nanospheres Target MEF2C to Suppress Muscle Atrophy in a Mechanical Unloading…
Circular RNA VANGL1 Facilitates Migration and Invasion of Papillary Thyroid Cancer by Modulating the…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Diagnostic Biomarkers for Adult Hemophagocytic Lymphohistiocytosis in Critically Ill Patients (HEMIC…
Determining Serum and Urinary Levels of miRNA 192 and miRNA 25 in Patients With and Without Type 2 D…
Blood microRNA Depression Change After DHCA
Study on the Clinical and Mechanism of Wenyang Huoxue Decoction in Treating Heart Failure After Myoc…
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients Wi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ